Views & Analysis Digital Health Round-up – NHS and Cerner, AMR study begins a... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Articles The superbug battle: O'Neill plan meets its own resistance f... suggestions that pharma should be levied to pay for a global fund have met their own resistance.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
